埃塞俄比亚西北部流行区HIV感染者伴或不伴内脏利什曼病的慢性高水平寄生虫血症:潜在超级传播者?
该研究嵌套于PreLeisH前瞻性队列(490例入组时无内脏利什曼病的HIV感染者,随访24-37个月),报告10例慢性内脏利什曼病(随访期间≥3次发作)和3例无症状利什曼原虫感染者的血利什曼原虫PCR结果。慢性内脏利什曼病者几乎整个随访期血PCR强阳性(中位循环阈值26,IQR 23-30),包括治疗间期;3例无症状感染者同样呈强寄生虫血症长达24个月而未发展为内脏利什曼病。作者认为无症状和症状性利什曼原虫感染的HIV感染者可能具有高传染性,构成利什曼原虫超级传播者,需异体接种诊断研究确认。
要点
- 10例慢性内脏利什曼病HIV感染者几乎整个随访期血利什曼原虫PCR强阳性(中位循环阈值26,IQR 23-30),包括治疗间期。
- 3例无内脏利什曼病者的HIV感染者同样呈强寄生虫血症长达24个月而未发展为内脏利什曼病。
- 作者认为无症状和症状性利什曼原虫感染的HIV感染者可能具有高传染性,构成超级传播者。
核心结论
- 这是首份来自利什曼原虫(Leishmania donovani)流行区HIV感染者慢性寄生虫血症的数据。
- 伴无症状和症状性利什曼原虫感染的HIV感染者可能具有高传染性,构成利什曼原虫超级传播者。
- 需异体接种诊断研究确认其传染性。
研究设计与样本
- 本研究嵌套于PreLeisH前瞻性队列研究,在埃塞俄比亚西北部随访490例入组时无内脏利什曼病的HIV感染者,随访长达24-37个月。
- 系统性进行血利什曼原虫聚合酶链反应(PCR)检测。
- 本病例系列报告10例慢性内脏利什曼病(随访期间≥3次发作)HIV感染者,随访长达37个月,以及3例无症状利什曼原虫感染者,随访长达24个月。
主要发现
- 10例慢性内脏利什曼病者均为男性,均在接受抗逆转录病毒治疗,入组前有0-11次复发,基线CD4计数中位数82 cells/µL。
- 10例慢性内脏利什曼病者在长达37个月的期间内出现3-6次内脏利什曼病治疗发作。
- 10例慢性内脏利什曼病者血利什曼原虫PCR几乎整个随访期强阳性(中位循环阈值26,IQR 23-30),包括内脏利什曼病治疗间期。
- 3例无内脏利什曼病病史的无症状利什曼原虫感染HIV感染者,在长达24个月的期间内呈同等强度的利什曼原虫寄生虫血症,未发展为内脏利什曼病。
- 3例无症状感染者入组时均在接受抗逆转录病毒治疗,基线CD4计数范围为78至350 cells/µL。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People with human immunodeficiency virus (PWH) with recurrent visceral leishmaniasis (VL) could potentially drive Leishmania transmission in areas with anthroponotic transmission such as East Africa, but studies are lacking. Leishmania parasitemia has been used as proxy for infectiousness. METHODS: This study is nested within the Predicting Visceral Leishmaniasis in HIV-InfectedPatients (PreLeisH) prospective cohort study, following 490 PWH free of VL at enrollment for up to 24-37 months in northwest Ethiopia. Blood Leishmania polymerase chain reaction (PCR) was done systematically. This case series reports on 10 PWH with chronic VL (≥3 VL episodes during follow-up) for up to 37 months, and 3 individuals with asymptomatic Leishmania infection for up to 24 months. RESULTS: All 10 chronic VL cases were male, on antiretroviral treatment, with 0-11 relapses before enrollment. Median baseline CD4 count was 82 cells/µL. They displayed 3-6 VL treatment episodes over a period up to 37 months. Leishmania blood PCR levels were strongly positive for almost the entire follow-up (median cycle threshold value, 26 [interquartile range, 23-30]), including during periods between VL treatment. Additionally, we describe 3 PWH with asymptomatic Leishmania infection and without VL history, with equally strong Leishmania parasitemia over a period of up to 24 months without developing VL. All were on antiretroviral treatment at enrollment, with baseline CD4 counts ranging from 78 to 350 cells/µL. CONCLUSIONS: These are the first data on chronic parasitemia in PWH from Leishmania donovani-endemic areas. PWH with asymptomatic and symptomatic Leishmania infection could potentially be highly infectious and constitute Leishmania superspreaders. Xenodiagnosis studies are required to confirm infectiousness.
引用
- van Griensven J, van Henten S, Kibret A, et al. Chronic High-Level Parasitemia in HIV-Infected Individuals With or Without Visceral Leishmaniasis in an Endemic Area in Northwest Ethiopia: Potential Superspreaders? Clin Infect Dis. 2024. PMID: 38193647. doi:10.1093/cid/ciae002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。